Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Exchange Rate Effect (2020 - 2026)

Pharvaris' (PHVS) quarterly Exchange Rate Effect came in at $4.9 million in Q1 2026, up 183.79% YoY from $1.7 million in Q1 2025, and up 5398.82% on a QoQ basis from $88541.8 in Q4 2025.

Analysis

Pharvaris (PHVS) Exchange Rate Effect (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 7 years of Exchange Rate Effect data on file, last reported at $4.9 million in Q1 2026.

  • Quarterly Exchange Rate Effect rose 183.79% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 306.13% YoY) and the FY2025 annual result came in at -$14.0 million, down 273.11% from the prior year.
  • Exchange Rate Effect grew to $4.9 million in Q1 2026, from $88541.8 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $752.6 billion in Q3 2023 to a low of -$752.8 billion in Q2 2023.
  • A 5-year average of -$13.1 million and a median of $88541.8 in 2025 frame the typical range for Exchange Rate Effect.
  • The widest YoY moves for Exchange Rate Effect: up 6439040.72% in 2023, down 6196390.97% in 2023.
  • Tracing PHVS's Exchange Rate Effect over 5 years: stood at -$15.6 million in 2022, then surged by 65.38% to -$5.4 million in 2023, then jumped by 299.46% to $10.8 million in 2024, then slumped by 99.18% to $88541.8 in 2025, then jumped by 5398.82% to $4.9 million in 2026.
  • The last three Exchange Rate Effect figures came in at $4.9 million (Q1 2026), $88541.8 (Q4 2025), and -$37999.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -300,000.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -2.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.84 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.45 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -287,000.00
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 3.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.81 Mn
Mar 31, 2026 4.87 Mn
Dec 31, 2025 88,541.81
Sep 30, 2025 -37,998.97
Jun 30, 2025 -7.85 Mn
Mar 31, 2025 -5.81 Mn
Dec 31, 2024 10.78 Mn
Sep 30, 2024 -3,525.40 Bn
Jun 30, 2024 3,456.92 Bn
Mar 31, 2024 627,925.79
Dec 31, 2023 -5.40 Mn
Sep 30, 2023 752.57 Bn
Jun 30, 2023 -752.80 Bn
Mar 31, 2023 -1.48 Mn
Dec 31, 2022 -15.61 Mn
Sep 30, 2022 -14,947.59 Bn
Jun 30, 2022 15,819.06 Bn
Mar 31, 2022 3.86 Mn
Dec 31, 2021 4.52 Mn
Sep 30, 2021 5.14 Mn